Pulmonary heart disease, medically termed cor pulmonale, manifests as a condition marked by the enlargement and impaired function of the right ventricle of the heart. Unlike diseases originating in the left side of the heart, pulmonary heart disease is primarily driven by elevated pressure in the pulmonary arteries. These vessels play a vital role in transporting blood from the heart to the lungs for oxygenation. The genesis of pulmonary heart disease often lies in prolonged instances of heightened blood pressure within the pulmonary arteries. This heightened pressure is frequently a consequence of underlying chronic respiratory ailments such as chronic obstructive pulmonary disease (COPD), pulmonary hypertension, and various interstitial lung diseases. The persistent strain on the pulmonary circulation prompts the right ventricle to intensify its pumping efforts, leading to enlargement and, potentially, eventual failure.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation